Aatru Medical

Executive Summary

Aatru Medical is a privately held medical device company headquartered in Cincinnati, Ohio, specializing in innovative wound care technologies, particularly Negative Pressure Wound Therapy (NPWT) systems. Its flagship product, NP SIMS, is designed for surgical incision management, offering a clinically effective, safe, and affordable alternative to traditional NPWT devices. Founded in 2015, the company focuses on improving patient outcomes and clinician experience through its proprietary platform. As a private entity with limited public disclosures, Aatru operates in the competitive wound care market, with its technology positioned to address the growing demand for advanced surgical site management and infection prevention. The NPWT market is expanding steadily, driven by rising surgical volumes and increasing awareness of post-operative complications. Aatru's value proposition lies in its cost-effective, user-friendly system that may lower barriers to adoption in both hospital and outpatient settings. However, the company faces challenges from established players and must achieve key regulatory and commercial milestones to gain traction. Future growth hinges on FDA clearance for its core product, successful market entry, and potential strategic partnerships. Overall, Aatru represents a promising but early-stage opportunity in the wound care space, with execution risk remaining elevated until clear proof of commercial viability emerges.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) Clearance for NP SIMS70% success
• H1 2027Initial Hospital System Contracts60% success
• Q3 2026Series A Funding Round50% success